While melanoma established the clinical foundation for oncolytic virus therapy, glioblastoma and central nervous system tumors represent a frontier of profound unmet need where the blood-brain barrier, immunologically privileged environment, and dismal prognosis create compelling rationale for viral approaches. Glioblastoma multiforme (GBM), the most common and aggressive primary brain tumor...